Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

China flag China · Delayed Price · Currency is CNY
20.71
-0.32 (-1.52%)
Sep 26, 2025, 3:05 PM CST
-9.76%
Market Cap 49.58B
Revenue (ttm) 12.73B
Net Income (ttm) -812.94M
Shares Out 2.39B
EPS (ttm) -0.34
PE Ratio n/a
Forward PE 63.78
Dividend 0.20 (0.97%)
Ex-Dividend Date Dec 25, 2024
Volume 22,865,111
Average Volume 31,039,770
Open 20.93
Previous Close 21.03
Day's Range 20.65 - 20.95
52-Week Range 18.70 - 40.43
Beta 0.76
RSI 36.91
Earnings Date Oct 27, 2025

About SHE:300122

Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysacchar... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7,220
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300122
Full Company Profile

Financial Performance

In 2024, SHE:300122's revenue was 26.07 billion, a decrease of -50.74% compared to the previous year's 52.92 billion. Earnings were 2.02 billion, a decrease of -74.99%.

Financial Statements

News

There is no news available yet.